de Carvalho Reis Erik Neiva Ribeiro, Bezerra Júnior Germano de Lelis, de Freitas Silva Leonardo, Braga Polo Tárik Ocon, de Amorim Rayane Aquino, Ponzoni Daniela, Okamoto Roberta, de Molon Rafael Scaf, Faverani Leonardo Perez, Garcia Junior Idelmo Rangel
Department of Diagnosis and Surgery, Sao Paulo State University - UNESP, Araçatuba Dental School, Rua José Bonifácio, 1193. Vila Mendonça, Araçatuba, São Paulo, 16015-050, Brazil.
Residency Program Advanced Education in General Dentistry (AEGD) and Master of Science in Dental Science, University of Rochester Eastman Institute for Oral Health, Rochester, New York, USA.
Oral Maxillofac Surg. 2025 May 5;29(1):95. doi: 10.1007/s10006-025-01390-y.
This study aimed to evaluate the bone repair process of standardized calvaria defects in rats treated with different bone substitute materials.
Critical size bone defects with 7 mm diameter were created in the right parietal bone of forty-eight rats using a trephine burr. The animals were randomly allocated to four different experimental groups according to the materials used to fill the defect, as follow: (1) Autogenous group: defects were filled with autogenous bone; (2) Bio-Oss group: defects were filled with demineralized bovine bone mineral; (3) EMD group: defects were filled with Emdogain; and (4) EMD + Bone group: defects were filled with a combination of both Bone Ceramic and Emdogain. Euthanasia was performed after 30 and 60 days.
Histometric analysis demonstrated for the 30-day period that all groups presented areas of bone neoformation, with the EMD + Bone group showing increased percentage of bone neoformation. For the 60-day period, there was a trend towards greater bone neoformation compared to the 30-day period, with a statistically significant difference between the EMD + Bone vs. Bio-Oss groups (p = 0.036). The percentage of new bone formation was significantly higher in the autogenous group compared to all the others. Moderate immunostaining of osteocalcin was observed in all groups at 30 days, which increased significantly in the 60-day period.
This study demonstrated suitable biological properties in the association of Emdogain with Bone Ceramic. However, further laboratory studies are needed to evaluate the osteoinductive properties of these materials, as well as their behavior in humans through clinical studies.
Not applicable.
本研究旨在评估用不同骨替代材料治疗的大鼠标准化颅骨缺损的骨修复过程。
使用环钻在48只大鼠的右顶骨上制造直径为7毫米的临界尺寸骨缺损。根据填充缺损所用的材料,将动物随机分为四个不同的实验组,如下:(1)自体骨组:缺损用自体骨填充;(2)Bio-Oss组:缺损用脱矿牛骨矿物质填充;(3)EMD组:缺损用Emdogain填充;(4)EMD + 骨组:缺损用骨陶瓷和Emdogain的组合填充。在30天和60天后实施安乐死。
组织计量学分析表明,在30天期间,所有组均呈现骨新形成区域,EMD + 骨组的骨新形成百分比增加。在60天期间,与30天期间相比,有更大骨新形成的趋势,EMD + 骨组与Bio-Oss组之间存在统计学显著差异(p = 0.036)。自体骨组的新骨形成百分比明显高于所有其他组。在30天时,所有组均观察到骨钙素的中度免疫染色,在60天期间显著增加。
本研究表明Emdogain与骨陶瓷联合具有合适的生物学特性。然而,需要进一步的实验室研究来评估这些材料的骨诱导特性,以及通过临床研究评估它们在人体中的行为。
不适用。